Tuesday, 9 September 2014

» Prosensa announces Lancet Neurology publication of an exploratory phase II study of Drisapersen Action Duchenne

» Prosensa announces Lancet Neurology publication of an exploratory phase II study of Drisapersen Action Duchenne: "Prosensa announces Lancet Neurology publication of an exploratory phase II study (DEMAND II) demonstrating efficacy and safety of drisapersen in patients with Duchenne muscular dystrophy"



'via Blog this'

No comments:

Post a comment